|
Merck Withdraws Bid For EU Regulatory OK Of Asthma Medicine
NASDAQ (MRK) has withdrawn its application for European regulatory approval of an asthma treatment, citing outstanding questions by regulators. … |
View full post on asthma – Google News
Breathe Well Live Well